
A Phase I Study of Gefitinib with Concurrent Dose-Escalated Weekly Docetaxel and Conformal Three-Dimensional Thoracic Radiation Followed by Consolidative Docetaxel and Maintenance Gefitinib for Patients with Stage III Non-small Cell Lung Cancer
Keywords: گیرنده فاکتور رشد اپیدرمال; Chemoradiation; Lung cancer; Epidermal growth factor receptor; Pulmonary toxicity